Member Info for Jonah58

Lots of companies trade on AIM with billions of shares worth fractions of a penny. It's the product of the two that counts. You should compare the market cap with other companies to get an idea of their 'size', though Jubilee's market cap should, and will, be quite a bit more than the current discounted value. You should do well with your investment here. Welcome.

Welcome on-board British-M. I doubt you'll even notice the 0.5p premium you paid for your shares. As you say, thay are a snip at the price. I tend to err on the gloomy side, but it seems unlikely you'll be any less than 100% up by this time next year.

Very interesting article. Thanks Billy and Jammer. It looks an unholy mess. I hope we retain our rights to process the dump when all of this is over. Could be a while though!

Mikie, I think we will have to announce it by RNS as it's price sensitive. It may not be an aquisition pure and simple. LC seems very adept at deal-making. It could be another joint venture - in fact it probably is.

Has Slater been buying Vikrant's shares?

Anyone know anything about Slater Investments?

We know from previous interviews that we are doing some sort of a deal to access another 30M + of tailings. Once we have at least a MOU there will be an RNS with some details, though it usually leaves unanswered questions! It should drop before Christmas. Meanwhile, sit back and watch our prolific gains consolidate on good volume.

NS. Leon has said we are building 3 concentrators. I am working on the assumption that the 30MT+ resource we are waiting news for is near enough to one of the other dumps to share its concentrator.

I'm with Moneyhawk on this one in that I attribute no value to Tjate in my calculations, and will continue to do so until some definite news is forthcoming. The future of Tjate is bound up in the future of the motor vehicle. Unlike TbT I do not see the increasing use of electric vehicles as a major headwind for PGMs as I strongly believe there will also be a huge swing towards a hydrogen economy. Of more concern is promising research on cheaper non-PGM catalysts but they are not ready yet. I hope JLP never gets involved with mining Tjate, but I do feel it will come into play one day, no doubt packaged with a neighbour as CB has hinted. For my money, the ideal solution would be sell it for a song and negotiate a long term royalty.

Sharehunter - can you clarify what you mean by 'FDA approval'. Are you referring to our application for a provisional license based on safety data alone? I'm often wrong, but I think this outcome is unlikely.
If it's not that, then there is nothing really for the FDA to approve. The meeting would have covered technical aspects of the phase 3 trial design, particularly the thorny issue of end points, the idea being to conduct a trial which, if positive in outcome, will lead to FDA approval.

I believe such a trial is within our grasp and that a positive outcome is more likely than not, which is why I've bought back in. I do not expect to make 300%. any time soon. If the Sp was 180p prior to the last trial reporting, it is unlikely to reach those heights before the next rrial reports as we have lost potential revenue from our biggest market (USA). Eventually we could become a multibagger but that's at least three years down the line during which all sorts of things could happen, good and bad.

I'm not the person to ask, Hads. I'm interested in trials but don't understand price movements. Prior to the last trial reporting the Sp rocketed to 180p. Since then we have forfeited the American rights to Avion (though we would earna royalty). Even so, it gives some idea of the massive potential of this share. I have bought back in recently.

There will be posts from lots of better informed people here. I think they will all agree though that it's a punt- not for widows and orphans ets etc

MrBen and Had. There has been a lot of water under the bridge. Udin's post is an odd mixture of reasonably new news and old stuff. The first phase three trial showed that lupuzor was no better than placebo in the treatment of lupus. Subgroup analysis, however, showed that some people with a particular profile benefitted and the drug was well tolerated (a huge advantage over existing therapies). Avion are sponsoring a second trial which I suspect will home in on the patients most likely to benefit. Details of this were discussed at a recent meeting with the FDA and I cannot wait to sift through these., especially the inclusion criteria and predefined end points.
Getting this trial going is likely to boost the Sp, though the real crunch will not come until it reports (I guess in 2 to 3 years).

Of course, Imm is not a one track pony, but lupuzor is the lead product.

Good points, Bruce, but I would refer to Conroast as a recipe rather than a design. It is, as you say, to do with smelting in an environmentally friendly way and avoiding the build up of damaging matte within the furnace. As we are not smelting at the moment the expiry of the patetnt is of little concern.

The technology and processes behind our fine chrome facility have been available for a while and, as such, would not be amenable to patent protection, though obviously we have been very clever putting it together and anyone else who wants to do it will either have to play catch-up or ask us to help. The crucial point was made by Jammer - the idea exports to the separation of 'fine copper' bringing tailings material into play that was previously thought to be uneconomic to process.

Not bothered by the slight retrace today. Only to be expected. I'm very happy that we are holding onto most of the gains with decent volume. I've been selling a few into each rise. Always happy to bank a profit and am happy for others to do better than me. My next selling point is 17p.

https://asia.nikkei.com/Spotlight/Environment/Japan-to-bet-big-on-hydrogen-to-meet-2050-zero-emission-goal

Report from Nikei that Japan plans to move to a dominant hydrogen economy by 2030 which is quite soon. In particular they will be using surplus wind and photoelectric power to generate hydrogen from water. Toyota has set up a hydrogen association. 88 major companies already signed up. Demand for catalysts will be huge.

Chaise: JLP hasn't mined anything and I hope it never does. It flirted with a mine called Smokey Hill but that came to nothing ages ago. I suspect extraction costs, by which I mean the costs of processing surface material to form a concentrate, will remain stable.

Someone exercising ca 600,000 warrants at just over 6p. Don't blame them!

799. I don't think you have missed out on low prices. Quite the opposite. I never ramp, but others on this board have made perfectly reasonable (I would say conservative) estimates of future earnings and even factoring in an equally conservative P/E ration we come up with a 3 bagger within two years.
So why are we not at that level now? Of course it's natural on these boards to concentrate on the positives, but professional investors will also be factoring potential risks, be they political in the jurusdictions where we operate, trade wars with China, currency fluctuations and market instability. As this company becomes increasingly derisked, institutional investmernt will continue to grow and I dare to wonder if some of the wilder predictions, seemingly plucked from the air, might not be as unrealistic as I first thought.

Thanks Patrick. Stimulating article. Mikie, Leon said the new deal will bring our total reserves 'north of 300 M tonnes'. As we already have access to 270 M tonnes, I expect the new arrangement to be north of 30 million tonnes! Of course, these are all joint ventures which will affect our share of each deal, but not the longevity of the combined projects.

Spot on, Jammer. We never got much detail about the copper material that just seemed to be lying about when we bought Sable. Was it tailings or RoM? (I use the past tense as I presume we have used it all up. I think we had to, actually, to fulfill a sulphuric acid supple obligation). I'm also in the dark as to whether there is a tailings concentrating facility at Sable. Pretty irrelevant, I suppose, as we will be constructing bespoke concentration plants at Roan (under construction), Elephant (in design) and Kitwe (6 to 9 months after Elephant).
The original plan was to reconfigure Sable so that production could easily be switched between Cu and Zn, but Zn seems to be taking the back seat. We have, however, been reassured that we will progress Zn in H2 2021. In fact we need to in order to maintain those green credentials people here are talking about. Cleaning up Kabwe may be less profitable in the short term, but it is central to our longer term prospects.